NCT06018948View on ClinicalTrials.gov

Effect of Two Different Doses of Dexmedetomidine Infusion in Morbidly Obese Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
AnesthesiaObesity, MorbidDexmedetomidine
Interventions
DRUG

Dexmedetomidine 0.6

Patients received a bolus dose of 1μg/kg Dexmedetomidine, 15 minutes after endotracheal intubation over 10 minutes followed by infusion of 0.6 μg/kg/hr for one hour.

DRUG

Dexmedetomidine 0.3

Patients received a bolus dose of 1μg/kg Dexmedetomidine, 15 minutes after endotracheal intubation over 10 minutes followed by infusion of 0.3 μg/kg/hr for one hour.

DRUG

Saline

Patients received over 10 minutes comparable volume of normal saline (0.9%) 15 min after endotracheal intubation followed by infusion.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06018948 - Effect of Two Different Doses of Dexmedetomidine Infusion in Morbidly Obese Patients | Biotech Hunter | Biotech Hunter